Metastatic Epidural Spinal Cord Compression

Overview

Metastatic epidural spinal cord compression (MESCC) is a neurologic and oncologic emergency in which a metastatic tumor within the vertebral column compresses the spinal cord or the cauda equina, threatening irreversible neurologic injury. In the great majority of cases the process begins in the vertebral body, where hematogenous tumor deposits expand and erode the posterior cortex, pushing tumor or displaced bone into the ventral epidural space. Less commonly, tumor reaches the epidural space through the intervertebral foramina or arises in the posterior elements of the spine. Compression injures the cord through both direct mechanical pressure and secondary vascular compromise: obstruction of the venous plexus triggers edema, demyelination, and eventually ischemic damage to the white matter tracts that carry motor and sensory signals.

The thoracic spine is affected most often, reflecting its large proportion of vertebral bone and its relatively narrow spinal canal, followed by the lumbosacral and then the cervical region. Multiple levels are commonly involved. The single strongest predictor of neurologic recovery is the patient's ambulatory and functional status at the moment treatment begins, making early recognition and same-day action essential.

What causes it

MESCC occurs when cancer spreads through the bloodstream to the bones of the spine. The primary cancers that most often produce cord compression are those with high skeletal tropism and high overall prevalence: carcinoma of the breast, lung, and prostate, along with multiple myeloma, renal cell carcinoma, and lymphoma. In children, sarcomas and neuroblastoma are leading causes.

Risk increases with the overall burden and duration of metastatic disease, with tumor types that dissolve bone (osteolytic histologies), and with vertebral lesions that have already breached the outer cortex of the bone. In some patients, particularly those with lung cancer or cancer of unknown primary, cord compression is the first recognizable sign of an underlying malignancy, so a high index of suspicion is warranted even when no cancer diagnosis has yet been made.

Symptoms and warning signs

The cardinal early symptom is back pain that is progressive, often described as deep or aching, and frequently worse when lying down or when bearing down (such as during coughing or straining). This pain often precedes any neurologic symptoms by weeks: a window during which early treatment can prevent irreversible injury.

As compression advances, patients develop:

• Motor weakness: typically in the legs, ranging from subtle heaviness to frank paralysis
• Sensory changes: numbness or altered sensation with a distinct level on the trunk below which sensation is abnormal
• Gait instability: unsteadiness or a sense that the legs are unreliable
• Bladder and bowel dysfunction: urgency, retention, or incontinence

When the cauda equina (the nerve roots below the end of the spinal cord) is involved rather than the cord itself, the pattern includes lower-limb weakness, saddle-area numbness, and sphincter disturbance.

Once dense paralysis and loss of sphincter control are established, they may be irreversible. Any combination of progressive motor deficit, a sensory level, or new sphincter disturbance in a patient with known or suspected cancer constitutes a true emergency requiring same-day imaging and oncologic and surgical consultation.

How it's diagnosed

Whole-spine MRI with and without gadolinium contrast is the imaging study of choice. It depicts bone marrow infiltration, the epidural soft-tissue mass, the degree of spinal cord deformation, and any additional lesions at other levels that would alter the treatment plan. Because multiple deposits are common, the entire spine is imaged even when symptoms point to a single level.

CT adds important detail about bony destruction and spinal stability, and guides surgical planning or percutaneous biopsy. CT myelography is used when MRI is contraindicated. Plain radiographs can appear entirely normal despite significant bone loss and should not be used to exclude the diagnosis.

When the primary cancer is unknown, image-guided biopsy, staging studies, and laboratory evaluation are needed to establish the histologic diagnosis. Imaging findings are always interpreted in the context of the patient's symptoms, functional status, and overall oncologic situation.

Treatment options

Management is urgent and multidisciplinary, involving neurosurgery, oncology, radiation oncology, and supportive care teams working in concert.

Corticosteroids, typically dexamethasone, are started promptly to reduce vasogenic edema around the compressed cord and stabilize neurologic function while definitive treatment is arranged. Pain control and venous thromboembolism precautions are initiated concurrently.

Definitive options depend on tumor radiosensitivity, spinal stability, degree of compression, neurologic status, and estimated life expectancy:

• Radiation therapy: Effective for radiosensitive tumors, including lymphoma, myeloma, and many breast and prostate metastases. Stereotactic body radiotherapy (SBRT) permits higher, more precisely targeted doses for selected lesions.
• Surgery with stabilization: Surgical decompression (removing tumor and displaced bone) combined with spinal instrumentation to restore stability. This is commonly followed by radiotherapy to address any residual tumor.
• Combined approach: Direct circumferential decompression followed by radiation has been shown to better preserve the ability to walk than radiation alone in appropriate surgical candidates.

Bone-modifying agents, systemic anticancer therapy, rehabilitation, and supportive or palliative care complete the treatment plan, with goals tailored to each patient's overall condition and preferences.

When surgery is considered

Surgery is the preferred approach when one or more of the following apply:

• The spine is mechanically unstable due to vertebral destruction
• Bone fragments are directly compressing the spinal cord
• The tumor type is resistant to radiation (radioresistant histology)
• The same spinal region has already received its full radiation dose
• Neurologic function is declining despite or before radiation

The goal of surgery is to decompress the cord, reconstruct the vertebral column, and provide durable stability, most often followed by radiation. Because outcomes are substantially better when surgery is performed before complete paralysis occurs, the decision should not be delayed. The surgical team evaluates each patient's anatomy, tumor biology, and overall health to determine whether and how surgery can best protect or restore neurologic function.